Carbamazepine: a neuropsychological and psychiatric profile.
D000293:Adolescent; D000328:Adult; D001288:Attention / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003071:Cognition / Q000187:drug effects; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D007696:Kindling, Neurologic / Q000187:drug effects; D007700:Kinetics; D007970:Leukopenia / Q000139:chemically induced; D008032:Limbic System / Q000187:drug effects; D008297:Male; D008568:Memory / Q000187:drug effects; D019964:Mood Disorders / Q000188:drug therapy; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000145:classification; D009483:Neuropsychological Tests; D009484:Neuropsychology; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D012895:Sleep, REM / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors; D005879:Tourette Syndrome / Q000188:drug therapy
D001798:Blood Proteins; D002220:Carbamazepine